Communications
DOI: 10.1002/anie.201005513
Peptide Coupling
Insights into the Finer Issues of Native Chemical Ligation:
An Approach to Cascade Ligations**
Zhongping Tan, Shiying Shang, and Samuel J. Danishefsky*
We have been studying the total synthesis of complex
glycopeptide and glycoprotein targets.[1] Pursuant to this
goal, we hope to discover broadly useful methods to join large
peptide and glycopeptide fragments while minimizing the
need for side-chain protection.[2] A field-changing contribu-
tion to the problem of polypeptide ligation, termed native
chemical ligation (NCL), was provided by Kent and co-
workers in 1994 (Scheme 1).[3] NCL involves the merger of a
We next turned to the possibility of extending NCL logic
to accomplish leucine ligation.[7] We first prepared the
diastereomeric b-thioleucine surrogates 1 [leu(SSMe)] and 2
[which we term leu(SSMe)*] (Scheme 2a). The synthesis of 1
commenced with commercially available (2S,3S)-3-hydroxy-
leucine (3) and passed through 4 and 5 as shown in Scheme 2.
Compound 2 was prepared through an analogous sequence
from (2S,3R)-3-hydroxyleucine (6).[4c,6a]
In addition to studying the feasibility and quality of the
projected leucine ligations, we anticipated that the availability
of two epimeric leucine surrogates (compounds 1 and 2) as
potential probes, could also provide a basis for studying rather
subtle, otherwise hidden issues of native chemical ligation.
Accordingly, we prepared the peptides described below
(Scheme 2b). In all cases, the acyl donor component of the
ligation was presented as a masked thiol ester of a type we had
previously described.[2a] The required peptides (vide infra)
with C-terminal methyl esters or free carboxylic acids and N-
terminal leucine surrogates were prepared using HATU-
Scheme 1. NCL and alanine ligation.
peptide domain possessing a C-terminal thioester fragment
with a second peptide bearing an N-terminal cysteine residue.
The key mechanistic features of NCL—transthioesterification
and S!N acyl transfer—are outlined in Scheme 1. Clearly if
the primary thio group could be desulfurized, the NCL
method can be used to accommodate alanine ligation.[4] Of
course, for this to work well, other sulfur moieties within the
construct must withstand the desulfurization reaction. A
major advance in this regard was accomplished in a metal-free
fashion, using classical mechanistic insights in free radical
mediated desulfurization.[5]
We then set about to apply, more generally, the overall
logic of NCL to other proteogenic amino acids. The thought
was to synthesize non-proteogenic amino acids, bearing
strategically placed thiol groups, to serve as the N-terminal
residues in the ligation event. In this way the logic of NCL
could, in principle, be broadly extended. In each case, the
concluding step would exploit our metal-free desulfurization
method. Indeed, this was accomplished for valine, lysine, and
threonine ligations.[6]
Scheme 2. Synthesis of peptide substrates. Reagents and conditions:
A) a) Boc2O, Na2CO3, THF/H2O, RT, 91%; b) TMSE-OH, DCC, DMAP,
CH2Cl2, 08C!RT, 99%; c) MsCl, Et3N, CH2Cl2, 08C; d) AcSK (excess),
DMF, RT, 408C!608C, 82% over two steps; e) NaOH, MeOH, 08C;
f) MMTS, DIEA, CH2Cl2, RT, 79% over two steps; g) TBAF, THF, RT,
98%. B) a) MeOH, DCC, DMAP, CH2Cl2; b) piperidine, CH2Cl2; c) Boc-
Leu(SSMe)-OH, HATU, DIEA, DMSO; d) TFA/H2O/TIS (95:2.5:2.5);
e) EDCI, HOOBt, CHCl3/TFE. TMSE=trimethylsilylethyl, DCC=dicy-
clohexylborane, DMAP=4-dimethylaminopyridine, AcSK=potassium
thioacetate, DMF=dimethylformamide, MMTS=methane methylthio-
sulfonate, DIEA=ethyldiisopropylamine, TBAF=tetrabutylammonium
fluoride, Boc=tert-butyloxycarbonyl, HATU=O-(7-azabenzotriazol-1-
yl)tetramethyluronium hexafluorophosphate, DMSO=dimethylsulfox-
ide, TFA=trifluoroacetic acid, TIS=triisopropylsilane, EDCI=N’-(3-
dimethylaminopropyl)-N-ethylcarbodiimide, TFE=2,2,2-trifluoroetha-
nol.
[*] Prof. S. J. Danishefsky
Department of Chemistry, Columbia University
3000 Broadway, New York, NY 10027 (USA)
Fax: (+1)212-772-8691
E-mail: s-danishefsky@ski.mskcc.org
Dr. Z. Tan, Dr. S. Shang, Prof. S. J. Danishefsky
Laboratory for Bioorganic Chemistry
Sloan-Kettering Institute for Cancer Research
1275 York Avenue, New York, NY 10065 (USA)
[**] Support for this research was provided by the National Institutes of
Health (CA28824 to S.J.D.).
Supporting information for this article is available on the WWW
9500
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2010, 49, 9500 –9503